Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Clinical trial NCT06118086 · RECRUITING
Trial details
- NCT number
- NCT06118086
- Sponsor
- Remix Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2027-09-30
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.